Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
BridgeBio Oncology Therapeutics, Inc (BBOT) had Weighted-Average Shares Outstanding (Diluted) of 43.49M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-44.76M |
|
-- |
|
-- |
|
$49.18M |
|
$-49.18M |
|
$4.42M |
|
$-44.76M |
|
$-44.76M |
|
$-44.76M |
|
$-44.76M |
|
$-44.76M |
|
$-44.76M |
|
$-49.18M |
|
$-49.18M |
|
43.49M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
43.49M |
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$476.01M |
|
$0.83M |
|
$8.78M |
|
$484.79M |
|
$35.71M |
|
-- |
|
$2.38M |
|
$38.09M |
|
$446.70M |
|
$446.70M |
|
$446.70M |
|
79.20M |
|
| Cash Flow Statement Financials | |
$-71.66M |
|
$65.56M |
|
$383.99M |
|
$30.98M |
|
$408.87M |
|
$377.89M |
|
$2.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-72.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.02% |
|
-10.02% |
|
-9.23% |
|
-10.02% |
|
$5.64 |
|
$-1.66 |
|
$-1.65 |
|